April 27, 2018 / 5:48 AM / 25 days ago

BRIEF-Recipharm Q1 EBITDA Up At SEK 250 Million

April 27 (Reuters) - RECIPHARM AB (PUBL):

* Q1 EBITDA SEK 250 MILLION VERSUS SEK 159 MILLION YEAR AGO

* Q1 NET SALES SEK 1.51 BILLION VERSUS SEK 1.33 BILLION YEAR AGO

* JAN-MARCH OPERATING PROFIT (EBIT) AMOUNTED TO SEK 120 MILLION (46) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below